PharmiWeb.com - Global Pharma News & Resources

With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.

The 4th iPSC Drug Development and Manufacturing Summit is your longest standing and definitive iPSC focused industry platform showcasing cutting-edge advances across R and D through to manufacturing and analytical development to help you stay at the forefront of the iPSC cell therapy revolution.

With content split across our Research and Development and Manufacturing and Analytical Development tracks, this is the one-stop shop meeting for drug developers and academic thought leaders looking to streamline their route to the clinic and scale up their manufacturing processes.

Date and Time: Tuesday, 01 October 2024 at 08:00 to Thursday, 03 October 2024 at 17:00